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The aim of this work was to analyse the inﬂuence of overlapping genes on the evolution of hepatitis B
virus (HBV). A differential evolutionary behaviour among genetic regions and clinical status was found.
Dissimilar levels of conservation of the different protein regions could derive from alternative
mechanisms to maintain functionality. We propose that, in overlapping regions, selective constraints
on one of the genes could drive the substitution process. This would allow protein conservation in one
gene by synonymous substitutions while mechanisms of tolerance to the change operate in the
overlapping gene (e.g. usage of amino acids with high-degeneracy codons, differential codon usage
and replacement by physicochemically similar amino acids). In addition, differential selection pressure
according to the HBeAg status was found in all genes, suggesting that the immune response could be one
of the factors that would constrain viral replication by interacting with different HBV proteins during the
HBeAg(−) stage.
& 2013 Elsevier Inc. All rights reserved.Introduction
Hepatitis B virus (HBV) has a DNA genome and it replicates via
a RNA intermediate. The substitution rate of HBV is thus expected
to be determined by the low ﬁdelity of its reverse transcriptase,
but also, by the partial overlapping of the four open reading frames
(ORFs) encoding the polymerase (P), surface antigen (S), nucleo-
capsid (C) and X protein (X). Particularly, gene P accounts for the
third part of the genome and is overlapped with all the other
genes of the genome. Besides, regulatory signals are also
embedded in protein-encoding genes, and secondary structures
of the HBV RNA might constrain the number and nature of
substitutions occurring in the HBV genome (Baumert et al., 1998;
Beck and Nassal, 1998; Kidd and Kidd-Ljunggren, 1996).
Such a complex organisation of the HBV genome allows assuming
different rates of variation among sites along the genome. It is well
known that substitution rates are different at the three positions of
the codons due to selective constraints at the protein level, although a
bias in the rate differences could be expected in the HBV genomic
regions where two ORFs overlap. Besides, different types of over-
lapping might have different impacts on this bias (Krakauer, 2000).
Previous works have studied some aspects of the HBV evolutionary
behaviour (Mizokami et al., 1997; Yang et al., 1995; Zaaijer et al., 2007;
Zhang et al., 2010). However, a study from an overall point of viewll rights reserved.
d de Farmacia y Bioquímica,
d Autónoma de Buenos Aires
d).about the evolutionary characteristics of the complete HBV genome
on all major genotypes is still missing.
Chronic infections are characterised by an initial phase with
high serum HBV DNA levels and detection of HBeAg (HBeAg(þ)
stage). Most of the carriers eventually loses HBeAg and develop
antibody to HBeAg (HBeAg(−) stage) (Lok and McMahon, 2009).
The transition between these stages is a process known as HBeAg
seroconversion and would occur through an immune mechanism.
Thus, viral sequences obtained from HBeAg(þ) or HBeAg(−)
stages of the infection could retain information about the process
involved. Differences in selection pressures among these stages have
been proposed based mainly on the studies on gene C. Nevertheless,
those studies were performed without covering all major genotypes
(Abbott et al., 2010; Lim et al., 2007; Warner et al., 2011).
The aim of this work was to analyse the inﬂuence of overlapping
genes on the evolution of HBV, particularly: (a) to analyse the codon-
site nucleotide variation for the ﬁrst, second and third codon positions
of all the HBV genes, (b) to study selective pressures and synonymous
and nonsynonymous substitutions, (c) to analyse amino acid and
codon usages in HBV, and (d) to study the evolutionary characteristics
in relation to the HBeAg status.Results
Codon-site nucleotide variation
In order to evaluate the inﬂuence of the overlapping reading
frames on the nucleotide variation pattern in the HBV genome,
Fig. 1. (a) HBV genetic regions analysed (some examples of partitions are shown, see Table 1 for the complete list of partition), and (b) dN and dS estimates for all HBV genes.
aP nonoverlapping regions were analysed as a whole.
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positions of overlapping and nonoverlapping genetic regions were
estimated for Datasets A (Fig. 1a and Table 1).
As a result, in the nonoverlapping regions of genes P, C and X,
their respective third positions (3p, 3c and 3x) were the most
variable. The third position of gene P displayed the highest rate of
variation.
For the P/X overlapping region, position 3p/1x was the most
variable. In contrast, in other regions, the third codon positions of
genes overlapped with P were the most variable. In the P/preS-S
region, the most variable codon position was 1p/3preS-S, whereas
in the P/C region, the most variable codon position was 2p/3c,
although with a high standard error (SE) value.
In addition, the discrete gamma distribution was used to
characterise the among-site rate variation for each codon position
in all genetic regions. This analysis showed that three positions
(3p, 3c, 1p/3preS1) displayed α values higher than or equal to 1. In
addition, these three positions reached high substitution rates. It
means that most of the sites involved in these codon positions
displayed a uniform high substitution rate (Table 1). On the
contrary, all of the other codon positions in the genome showed
α<1, which means that a high substitution rate would be displayed
only for some of these sites.
Similar results were obtained on seven genotype-speciﬁc
HBeAg(þ) datasets (available upon request).Analyses of selective pressure and synonymous and nonsynonymous
substitutions
To characterise the pattern of selection that operates on the
HBV genome, two approaches were applied.
The ﬁrst method is particularly designed to analyse overlapping
genetic regions and allows ﬁnding signatures of purifying selection
on genes (pattern of conservation) comparing the expected and
observed number of synonymous and nonsynonymous substitu-
tions in both ORFs (Table 2). Signatures of purifying selection were
found in preS1, preS2 and S regions of ORF preS-S and in ORF P in
P/S and P/X regions.
The second method (SLAC) is one of the traditional approaches
commonly applied to study selective pressure. Here, it was used to
detect patterns of nonconservation and to compare the behaviour
of overlapping and nonoverlapping regions, which is not possible
using the ﬁrst method since it is focused on detecting purifying
selection on overlapping genes. This method accounts for an
independent estimation of dN and dS, which becomes especially
important when, as it occurs in HBV, a nonuniform distribution of
rates is present (Kosakovsky Pond and Frost, 2005).
Different analyses were performed with the SLAC method:i. First, to analyse overall patterns of conservation (dN<dS) or
nonconservation (dN>dS), the dS and dN values were
Table 1
Codon-site nucleotide variation.
HBV genetic regiona Partition Region length
(nucleotides)
Codon position Relative rate±SE α parameter
P/preS2 1 55 1p/3preS2 1b 0.91
2 55 2p/1preS2 0.243±0.072 0.33
3 55 3p/2preS2 0.587±0.139 0.77
P/preS1 4 119 1p/3preS1 1.190±0.214 1.83
5 119 2p/1preS1 0.497±0.106 0.53
6 119 3p/2preS1 0.278±0.061 0.62
P/S 7 227 1p/3s 0.505±0.097 0.23
8 227 2p/1s 0.112±0.026 0.21
9 227 3p/2s 0.246±0.051 0.35
Nonoverlapping P 10 311 1p 0.475±0.088 0.22
11 311 2p 0.244±0.055 0.16
12 311 3p 2.087±0.357 1.05
P/X 13 83 1p/2x 0.240±0.109 0.18
14 83 2p/3x 0.414±0.095 0.10
15 84 3p/1x 0.903±0.191 0.37
Nonoverlapping X 16 63 1x 0.599±0.139 0.48
17 64 2x 0.248±0.069 0.38
18 63 3x 0.780±0.184 0.45
Nonoverlapping C 19 156 1c 0.268±0.060 0.30
20 156 2c 0.094±0.025 0.21
21 156 3c 1.400±0.258 0.97
P/C 22 49 1p/2c 0.083±0.031 0.62
23 49 2p/3c 0.378±0.100 0.21
24 48 3p/1c 0.218±0.071 0.34
a Results of the C/X overlapping region are not shown because it is composed of less than 10 codons.
b Estimated substitution rates are relative to this position.
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was observed in all nonoverlapping regions and also in the
overlapping regions on ORF S (preS1 and preS2) and on ORF P
(P/X region) (Table 3). This last result is coincident with that
obtained from the ﬁrst method used. Besides the ﬁrst method
being the appropriate one to analyse selective pressures on
HBV given the overlapping nature of its genome, performing
the analysis using traditional methods (such as the SLAC)
allowed us to obtain results that did not disagree with those
obtained with the ﬁrst method. However, the purifying selec-
tion on P/S overlapping region in both ORFs was only detected
by the ﬁrst approach but not by the SLAC method. This is
consistent with the lower sensitivity of the SLAC method.
On the other hand, the nonconservative patterns were infre-
quent according to SLAC and occurred in overlapping regions
(P/preS1 –ORF P-, P/C –ORF P-, P/X –ORF X-) (Table 3).
Some results were notorious. A dual behaviour was observed in
some overlapping regions: while one of the genes showed a
conservative pattern, the overlapping gene showed a noncon-
servative one. This was observed for the P/X region (with a
dN<dS for gene P and dN>dS for gene X) and for the P/preS1
region (where the nonconservative pattern on gene P was
accompanied by a conservative pattern on the ORF preS-S).
Another noteworthy result was the pattern of conservation/
nonconservation in the P/S region. Given the high nucleotide
substitution rate of position 1p/3s (see Table 1), a nonconser-
vative pattern on gene P along the overlapping P/S region was
expected. However, purifying selection was observed. Then, the
mechanism that allows gene P to vary its ﬁrst codon positionwithout causing a high number of nonsynonymous changes
was further studied (see Amino acid and codon usages section).ii. The SLAC method was also applied to analyse the behaviour of
overlapping vs nonoverlapping regions of each gene. The dS
values were always higher in the nonoverlapping regions;
whereas, most of the dN values did not present signiﬁcant
difference between overlapping and nonoverlapping regions of
each gene (Table 3 and Fig. 1b). As an exception, gene P in the
overlapping P/preS1 and P/preS2 region showed dN values
higher than in the nonoverlapping region.iii. Finally, site-to-site selection was analysed. In this case, 31 sites
had a signiﬁcant dN>dS and 27 were found in overlapping
regions. Besides, 22 out of those 27 sites with dN>dS in an
overlapping reading frame were associated with sites having
signiﬁcant dN<dS in the other ORF (Fig. S1 and Table S3),
evidencing the interdependence of genes.
Similar results for the SLAC method were obtained on seven
genotype-speciﬁc HBeAg(þ) datasets (available upon request).
Amino acid and codon usages
To evaluate possible mechanisms of tolerance to the change in
HBV, amino acid and codon usages between overlapping and
nonoverlapping genetic regions were studied.
A differential amino acid usage was observed between the over-
lapping and the nonoverlapping regions of all genes. In particular, the
overlapping regions showed higher usage of amino acids codiﬁed by
six synonymous codons and lower usage of amino acids codiﬁed by
Table 3
dS and dN values for each HBV genetic region in the HBeAg(þ) dataset.
HBV genetic region ORF Region length
(codons)
dS dN dN vs dS p-value
(dN vs dS)e
Median 25–75% Percentile p-value
(dS vs dS)a
Median 25–75% Percentile p-value
(dN vs dN)a
P/preS1 preS-S 119 2.481 0.809–4.638 – 0.405 0.000–1.323 – dN<dS <0.001
P/preS2 55 1.619 0.000–4.918 – 0.809 0.000–1.829 – dN<dS <0.05
P/S 226 0.000 0.000–1.166 – 0.000 0.000–0.552 – >0.05
P/PreS1 P 118 0.000 0.000–0.922 <0.001b 1.157 0.559–2.157 <0.001b dN>dS <0.001
P/PreS2 55 0.583 0.000–2.049 <0.001b 0.862 0.000–1.612 <0.001b >0.05
P/S 227 0.000 0.000–0.915 <0.001b 0.000 0.000–0.420 >0.05b >0.05
P/C 48 0.000 0.000–0.000 <0.001b 0.123 0.000–0.409 >0.05b dN>dS <0.05
P/X 82 0.583 0.000–2.333 <0.001b 0.000 0.000–0.292 >0.05b dN<dS <0.001
Nonoverlapping P 309 3.499 1.081–5.852 – 0.000 0.000–0.583 – dN<dS <0.001
P/C preC-C 47 0.000 0.000–1.243 <0.001c 0.000 0.000–0.377 >0.05c >0.05
Nonoverlapping C 155 3.020 0.755–5.284 – 0.000 0.000–0.377 – dN<dS <0.001
P/X X 83 0.000 0.000–0.747 <0.001d 0.374 0.000–1.244 >0.05d dN>dS <0.01
Nonoverlapping X 62 1.048 0.000–3.452 – 0.346 0.000–1.121 – dN<dS <0.05
Signiﬁcant p-values (p<0.05) are shown in bold.
a Overlapping vs nonoverlapping regions within each gene.
b Compared with nonoverlapping P.
c Compared with nonoverlapping C.
d Compared with nonoverlapping X.
e Intra-region comparison.
Table 2
Signature of purifying selection on HBV overlapping regions.
Overlapping region ORF 1/p-valuea ORF 2/p-valuea Ts/Tvb Possible/Observed Nonsynonymous substitutions in ORF 2c Synonymous substitutions in ORF 2c
N2N1 N2S1 S2N1 S2S1
P/preS1 preS1 P Ts P 100.5 98.3 99.3 2.4
O 32.0 87.0 31.0 3.0
0.000 0.077 Tv P 360.8 116.4 118.1 5.7
O 90.0 84.0 14.0 8.0
P/preS2 preS2 P Ts P 55.2 53.9 49.9 0.1
O 10.0 33.0 28.0 2.0
0.000 0.060 Tv P 197.4 68.8 50.6 1.1
O 18.0 26.0 5.0 1.0
P/S S P Ts P 228.4 208.4 216.6 19.1
O 21.0 38.0 51.0 23.0
0.000 0.003 Tv P 833.1 249.1 256.5 6.4
O 39.0 41.0 24.0 5.0
P/C C P Ts P 41.3 51.7 47.0 1.0
O 3.0 2.0 11.0 1.0
0.706 0.135 Tv P 159.8 48.2 69.4 4.6
O 10.0 3.0 9.0 4.0
P/X X P Ts P 79.2 79.5 81.8 4.6
O 9.0 15.0 41.0 3.0
0.159 0.000 Tv P 243.6 122.5 122.1 2.0
O 12.0 14.0 41.0 2.0
a Signiﬁcant p-values (p<0.05) are indicative of purifying selection and are shown in bold.
b Ts: transitions. Tv: transversions.
c N2N1: Nonsynonymous substitution on genes 2 and 1, N2S1: Nonsynonymous substitution on gene 2 and synonymous substitutions on gene 1, S2S1: Synonymous
substitution on genes 2 and 1, S2N1: Synonymous substitution on gene 2 and nonsynonymous substitutions on gene 1.
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P/S region, ORF P showed a high frequency of the amino acids serine
and leucine with respect to the nonoverlapping P region (data not
shown). These amino acids are codiﬁed by six synonymous codons
and for which a change on the ﬁrst codon position allows synonymous
changes to occur (although, in the case of serine, a change in the
second codon position is also needed). The increased usage of 6-fold
degenerate amino acids could explain the fact that the high variation
in position 1p/3s was not accompanied by an increase in the dN along
gene P (see “Codon-site nucleotide variation”, in Results section).On the other hand, if an amino acid change is committed,
almost all HBV genomic regions showed a higher probability of
nonsynonymous replacements with amino acids with similar
physicochemical characteristics than that expected by chance
(Observed vs Expected comparison, Table 4). However, this
mechanism was constrained in the overlapping regions, given
that, in general, they showed lower number of amino acid
substitutions within a single class that the nonoverlapping regions
of each ORF (Observed substitutions for overlapping vs nonover-
lapping regions, Table 4).
Table 4













P/preS1 preS-S 24.5 5.2 <0.001 –
P/preS2 19.7 8.2 <0.001 –
P/S 27.1 8.2 <0.001 –
P/preS1 P 15.7 7.6 <0.001 <0.001
P/preS2 28.7 5.9 <0.001 >0.05
P/S 22.8 11.0 <0.001 <0.05
P/C 30.8 10.3 <0.001 >0.05
P/X 20.8 8.9 <0.001 <0.01
Nonoverlapping P 28.9 7.9 <0.001 –
P/C preC-
C
5.9 5.1 >0.05 <0.001
Nonoverlapping C 47.2 9.5 <0.001 –
P/X X 12.4 9.1 <0.05 >0.05
Nonoverlapping X 14.9 7.9 <0.001 –
Signiﬁcant p-values (p<0.05) are shown in bold.
a Amino acid substitutions within a single class were counted according to the
classiﬁcation of the IMGT® database. The classes formed by more than one amino
acid were considered: Aliphatic (A, I, L, V), Basic (R, H, K), Sulphur (C, M), Hydroxyl
(S, T), Acidic (D, E), Amide (N, Q).
b Comparison between substitutions (Observed values) of overlapping regions
(or) and nonoverlapping regions (nr) of ORFs P, preC-C and X.
Table 5
Correlation analyses among relative synonymous codon usage values.





P/preS1 P 0.072 −0.195–0.329 >0.05a
P/preS2 0.032 −0.234–0.292 >0.05a
P/S 0.407 0.161–0.606 0.001a
P/C 0.184 −0.083–0.427 >0.05a
P/X −0.096 −0.351–0.171 >0.05a
P/C preC-C 0.333 0.076–0.548 0.01b
P/X X 0.159 −0.109–0.405 >0.05c
Nr vs liver genes – 0.286 0.025–0.511 <0.05d
Nr vs brain genes – 0.072 −0.195–0.329 >0.05e
Signiﬁcant p-values (p<0.05) are shown in bold.
a Compared with nonoverlapping P.
b Compared with nonoverlapping C.
c Compared with nonoverlapping X.
d Nonoverlapping regions vs highly expressed human liver genes.
e Nonoverlapping regions vs highly expressed human brain genes.
Fig. 2. Amino acid usage according to the level of degeneracy of codons for genes P,
preC-C and X in overlapping and nonoverlapping regions (a) and for different
regions of gene P (b). ⁎p<0.05 and ⁎⁎p<0.01 values corresponding to the comparison
between overlapping and nonoverlapping regions.
C. Torres et al. / Virology 441 (2013) 40–4844In addition, intra-region amino acid diversity was estimated to
evaluate the tolerance to the change in each genetic region.
Different regions showed dissimilar tolerance to nonsynonymous
changes. Gene P in the P/preS1 and P/preS2 regions showed the
highest amino acid diversity and thus, the highest tolerance to the
change (Table S4).
When the frequency of use of alternative codons was analysed,
the results showed that, in most cases, the codon usage in the
nonoverlapping region of each gene did not show a signiﬁcant
correlation with the one used in the overlapping regions (Table 5).
In contrast, the codon usage of the nonoverlapping HBV regions
did show correlation with the human codon usage of the liver-
speciﬁc highly expressed genes but not with brain-speciﬁc ones
(as representative of a tissue that does not sustain HBV replication)
(Table 5).
Differential adaptive evolution according to the HBeAg(þ)/(−) status
In order to analyse the evolutionary characteristics in HBV in
relation to the HBeAg status, two strategies were followed to
compare HBeAg(þ) and HBeAg(−) groups: the comparison of dN
and dS in both groups and the detection of differential selection
pressures on individual codon sites between both populations.
On one hand, the results showed that although both groups had
conservative patterns in the nonoverlapping C region, the HBeAg
(−) dataset was less conservative (the dN/dS ratio is higher in the
HBeAg(−) dataset), owing to a higher number of nonsynonymous
substitutions (dN) and a lower number of synonymous substitu-
tions (dS) (Table S5). In addition, in the overlapping P/S region the
HBeAg(−) dataset showed a nonconservative pattern in gene S
along with a conservative pattern in gene P, which was not
observed for the HBeAg(þ) group (Tables 3 and S5). Other feature
found in the HBeAg(þ) group and not in the HBeAg(−) dataset
include a conservative pattern in ORF S in P/preS2 and in
nonoverlapping X region and the nonconservative one in ORF P
in P/C region.On the other hand, sites that have a signiﬁcantly different dN/
dS ratios among the two populations were analysed. Five codons
in ORF preS-S, eight in P, 25 in preC-C and ﬁve in X were identiﬁed
as differentially selected between the HBeAg(þ) and HBeAg(−)
groups (p≤0.05) (Table S6). Most of the sites were associated with
a higher dN/dS ratio in the HBeAg(−) dataset and were related to
epitopes B and T.Discussion
The complex genetic organisation of HBV allows assuming a
different evolutionary behaviour along the genome. The evolution
of a genetic region with overlapping genes is under constraints,
since a nucleotide substitution would have impact, simultaneously,
on two genes. However, the direction and the relative strength of
C. Torres et al. / Virology 441 (2013) 40–48 45these constraints are not obvious and they have not yet been
comprehensively studied.
In this study, we showed that the nonoverlapping regions
present nucleotide patterns of variation, synonymous substitution
rates and amino acid and codon usages different from those of the
overlapping regions of the HBV genome.
Concerning the pattern of variation for codon positions, we
found that the nonoverlapping regions of the HBV genome
displayed the typical behaviour of nonoverlapping genes, whose
third positions varied with moderate or high substitution rates. On
the other hand, in the overlapping regions, the highest variation
was observed in the third position of one of the overlapping genes
but restricted to few sites (excepting overlapping P/preS1 that
showed an homogeneously high substitution rate), which means
that most of the sites that belonged to this third position remained
almost constant (see Table 1). Although the highest nucleotide
variation was observed in nonoverlapping regions, these regions
were more conserved from the point of view of amino acids. From
our results, the overlapping limited the synonymous substitutions,
increasing the dN/dS relation. According to the traditional meth-
ods to evaluate selective pressures, a dN>dS could be qualiﬁed as
“positive selection”. However, these nonsynonymous changes
could better represent a higher tolerance to the change, operating
on one of the overlapping genes, than a real positive selection. In
line with this, our results showed that the presumptive positive
selection detected on one ORF was generally accompanied by a
purifying selection on the overlapping ORF. It is worth noting that
none of the sites presenting dN>dS was associated with genotype-
speciﬁc polymorphisms, immunotherapy escape or failure in
detection by diagnostic kits (Weber, 2005; Zoulim and Locarnini,
2009; Zuckerman and Zuckerman, 2003).
Previously, it has been suggested an independent evolution of
HBV genes (Zaaijer et al., 2007). However, based on our results, we
propose that the substitution process in the overlapping regions of
the HBV genome would be driven by selective constraints that
operate on one of the genes, rather than on both, which has been
proposed for other viruses (Hughes and Hughes, 2005; Hughes
et al., 2001; Narechania et al., 2005; Pavesi, 2006). Thus, a protein
encoded in one frame would be relatively constrained by purifying
selection whilst the protein encoded in the other frame would
need to be able to tolerate amino acid changes. As a noteworthy
exception, the behaviour of genes S and P in the P/S region that
showed simultaneous purifying selection is also described here
(see later in Discussion).
As examples of the more general rule of constrained and
tolerant overlapping genes, a nonconservative pattern in gene P
was observed in the overlapping with the preS1, which conversely
exhibited a conservative pattern of changes (see Table 3). This
behaviour may be explained by the critical role of preS1 region in
the biology of HBV (Seeger and Mason, 2000), which might
constrain its amino acids changes. The amino acids codiﬁed into
the preS1 region, as part of the Large protein of the Surface
antigen, would participate as the viral anti-receptor and the ligand
for C particles during the virion assembly (Bruss et al., 1994;
Ostapchuk et al., 1994; Prange and Streeck, 1995). In this region,
gene P codiﬁes for the “Spacer” domain without a known function
in the infectious cycle of the HBV, which was able to tolerate
amino acids changes. Another example can be pointed out in the
overlapping P/X, in which the P protein codiﬁes for the C-terminal
region of the “RNAseH” domain that is responsible for the
degradation of the RNA template during reverse transcription
(Chen and Marion, 1996), displaying a conservative pattern of
substitution. Whereas, in this region, gene X codiﬁes for the N-
terminal end of X protein with an elusive role (Tang et al., 2005)
being able to tolerate a nonconservative pattern. Therefore, an
inverse relationship between the functional importance of regionsand the level of diversity has been found. This was previously
proposed for HBV based on partial sequences (Zhang et al., 2010),
although in this work it is demonstrated based on complete
genomes.
A dissimilar level of conservation displayed by different protein
coding regions could derive from the use of alternative mechan-
isms to maintain functionality, involving not the whole gene but a
partial region with a speciﬁc function, process that we call as a
“regional” evolution of genes.
Some mechanisms are here proposed to explain the tolerance
to the changes in different genetic regions:
First, an increase in the usage of amino acids with a high level
of degeneracy in the overlapping regions. This has been previously
shown to occur in other viruses such as coliphages, HIV-1 and
some avian HBV (Pavesi et al., 1997). Here, we also demonstrated
that this increase was at the expense of a decrease in the usage of
amino acids with a low level of degeneracy (see Fig. 2). This
mechanism might imply that nonsynonymous changes in one ORF
could be diminished by increasing the use of six-fold degenerate
amino acids that would allow synonymous substitutions by
changes in the ﬁrst codon position.
Second, a codon usage bias in most of the overlapping regions
of the HBV genome (see Table 5). This strategy, combined with the
previous one, could offer higher ﬂexibility (higher number of
options) to use codons that better stand the requirement of the
overlapping ORF.
Third, nonsynonymous replacements by amino acids with
similar physicochemical characteristics. This mechanism, common
in nonoverlapping genes, would allow virus to evolve even in
overlapping regions (see Table 4).
All these mechanisms can be exempliﬁed in the analysis of the
P/preS-S region, where position p1/preS-S3 was the most variable,
suggesting that nonsynonymous changes in gene P and synon-
ymous changes in the preS-S would prevail. This was conﬁrmed in
the P/preS region but failed to predict the evolutionary behaviour
of gene P in the P/S region, which showed low dN and even,
purifying selection. In other words, according to the analysis of
nucleotide variation the purifying selection acting on gene S in the
P/S region is not surprising; however, it is noteworthy to obtain
this ﬁnding in gene P. This dual purifying selection is very
infrequent in nature and probably reﬂects a long-term evolution
of this virus. This was previously reported on the complete P/preS-
S region (Sabath et al., 2011), although in this work it is demon-
strated that this pattern is driven only for the behaviour of the P/S
and not for the P/preS region (see Table 2).
Thus, the usage of amino acids with six synonymous codons in
gene P is the mechanism proposed to conserve the amino acid
sequence in the P/S region. Besides, the replacement of amino
acids with others that share physicochemical properties could also
be an evolutionary key to tolerate nonsynonymous changes in this
region of gene P, which corresponds to the Retrotranscriptase (RT)
domain. In this way the amino acids found in high frequency in the
RT would be codiﬁed by codons that better stand the requirement
of the S protein.
In addition, we tested the codon usage bias between nonover-
lapping HBV regions and human genes. This analysis showed that
HBV codon usage correlated with that of liver-speciﬁc but not with
brain-speciﬁc human genes, suggesting a high level of viral
adaptation to the main target tissue of its host, given that the
relative tRNA abundance might modulate the expression of pro-
teins (Hershberg and Petrov, 2008).
An important stage of the HBV chronic infection, the HBeAg
seroconversion, was also studied under this evolutionary perspec-
tive. Different investigators associated the HBeAg seroconversion
process with an increase in the number of nonsynonymous
substitutions (Abbott et al., 2010; Akarca and Lok, 1995; Lim
C. Torres et al. / Virology 441 (2013) 40–4846et al., 2007; van de Klundert et al., 2011). It has been hypothesised
that amino acid changes could be selected to avoid recognition by
the immune system (escape mutations) but also, not mutually
exclusive, that they might restore any loss of function (compensa-
tory mutations). However, most of the studies that evaluated these
possibilities focused on gene C (Abbott et al., 2010; Bertoletti et al.,
1994; Tsai et al., 1996). Here, we showed that the increase of
nonsynonymous substitutions was also detectable on genes P, X
and S during the HBeAg(−) phase of infection. Most of these amino
acid changes were located on described HBV epitopes (Khakoo
et al., 2000; Liu et al., 2011; Maman et al., 2011; Mizukoshi et al.,
2004; Nayersina et al., 1993; Norton et al., 2010; Rehermann et al.,
1995), which is consistent with an immune selection. Neverthe-
less, sites unrelated with epitopes were also found to be under
different selection pressures among the HBeAg(þ) and HBeAg(−)
populations. It is worth noting that none of the differentially
selected sites were related to sites previously associated with
antiviral therapy. These ﬁndings remark the importance of analys-
ing the full-length genome to have a complete outlook of the HBV
molecular evolution in relation to different clinical stages of the
infection.
On the other hand, factors other than the virus per se, which
were not considered along this work owing to the lack of
information, such as age of infection, time to HBeAg seroconver-
sion, population genetic background, etc., could be involved in
HBV molecular evolution (Chatzidaki et al., 2011; Liaw et al., 2011;
Locarnini and Zoulim, 2010; Singh et al., 2007; Wu et al., 2010).
Thus, the relative importance of these factors should be taken into
account to improve the understanding of the virus-host interac-
tion in HBV infections.Conclusions
A differential evolutionary behaviour among the HBV genetic
regions and HBV clinical status was found. The evolutionary process
in overlapping genes would allow protein conservation in one frame
by synonymous substitutions while mechanisms of tolerance to the
change or adaptation might occur in the other frame, including the
usage of amino acids codiﬁed by high-degeneracy codons, a differ-
ential codon usage and nonsynonymous substitutions by amino acids
with similar physicochemical properties. In addition, a differential
selection pressure according to the HBeAg status was found in all HBV
genes, increasing the evidence that the immune response could be one
of the factors that constrain viral replication by interacting mainly with
protein C but also with the other proteins. However, sites unrelated
with epitopes were also found, suggesting that other nonimmune
selective pressures could also be acting.Material and methods
Datasets
Complete genomes belonging to almost all major HBV genotypes
(A–F and H) – including 39 isolates previously sequenced in our
laboratory – were obtained from GenBank. Sequences were classiﬁed
as HBeAg(þ)/(−) according to the absence/presence of molecular
markers of HBeAg(−) status: (a) mutations G1896A or AG1762/4TA,
(b) absence of the ATG preC translational initiation codon, and (c)
presence of any stop codon in the preC region (Brunetto et al., 1989;
Carman et al., 1989; Günther, 2006; Yim and Lok, 2006). Sequences
with insertions, deletions or internal stop codons in any ORF as well as
recognised or potentially proposed recombinant sequences were
excluded from the analysis (Kramvis et al., 2008; Morozov et al.,
2000; Simmonds and Midgley, 2005). Genotype G was excludedbecause it possesses two constitutive translational stop codons at
positions 2 and 28 of the preCore region, whereas the recently
proposed genotypes I and J were excluded because of the lack of
suitable sequence representation in databases (Tatematsu et al., 2009;
Tran et al., 2008).
All analyses performed on this work were based on a dataset
composed of sequences classiﬁed as HBeAg(þ) with an equili-
brated representation of the genotypes (n sequences¼140) (Data-
set A). In addition, analyses of selective pressures mentioned
below were also performed on a dataset composed of sequences
classiﬁed as HBeAg(−) with an equilibrated representation of the
genotypes (n sequences¼119) (Dataset B)
The nucleotide sequence accession numbers used in this work
can be found in the Supplementary material (Tables S1 and S2).
Codon-site nucleotide variation
The magnitude and uniformity of the codon-site variation
were evaluated under a Maximum Likelihood approach imple-
mented in the Baseml module of PAML v4.1 package (Yang,
2007).
The magnitude of the variation was studied estimating relative
substitution rates for the ﬁrst, second and third codon positions.
The genetic regions analysed were preS1, preS2, S, preC-C, X and P,
in both overlapping and nonoverlapping regions (Fig. 1a). Align-
ments and phylogenetic trees were used as input for the analysis.
Sequences were aligned with ClustalX v2.0.5 (Thompson et al.,
1997) and edited with Bioedit v7.0.9.0 (Hall, 1999). Maximum
Likelihood (ML) phylogenetic trees were obtained by using the
PhyML v3.0 software (Guindon and Gascuel, 2003) with the
nucleotide substitution model estimated with the jModeltest
v0.1.1 software (Posada, 2008) according to the Akaike Information
Criterion.
For this analysis, the complete genome was divided into eight
regions: overlapping P/preS1, P/preS2, P/S, P/X, P/C, and non-
overlapping P, X and C; and each codon position was analysed,
resulting in 24 different partitions corresponding to each codon
position in each of the eight regions (see Fig. 1a and Table 1 for
an exempliﬁcation and deﬁnition of the partititions). For
instance, partition 1 grouped the nucleotides at the ﬁrst codon
position of P in the P/preS2 overlapping region that corresponds
to the third position of preS2 (1p/3preS2), while partition 10
grouped the nucleotides at the ﬁrst codon position in the P
nonoverlapping region (1p). The three partitions of the C/X
overlapping region were not considered since they are formed
by less than 10 nucleotides.
The uniformity of variationwas studied estimating the α parameter
value of the function of the gamma distribution for each partition. This
function can be used to describe the variation in substitution rates
over nucleotide sites and then, from the estimation of the α parameter
(which confers the shape on the function) it would be possible to infer
the level of substitution rate uniformity (Yang, 1994). Then, α values
lower than 1 represent extreme rate variation (combination of some
sites varying with very high substitution rates and others with low
rates) and α values higher or equal than 1 represent a high uniformity
among substitution rates (Yang and Kumar, 1996). Thus, for each
partition, a gamma distributed function was assumed and the α
parameter value was estimated.
Analyses of selective pressure and synonymous and nonsynonymous
substitutions
To study synonymous and nonsynonymous substitutions and
selectives pressures on HBV two approaches were used.
First, a method particularly designed to analyse multiple align-
ments of related sequences with overlapping genetic regions was
C. Torres et al. / Virology 441 (2013) 40–48 47applied (Sabath et al., 2011). This method estimates the observed
and expected number of synonymous and nonsynonymous sub-
stitutions in both ORFs and allows ﬁnding signatures of purifying
selection on genes. Brieﬂy, the method consists of the construction
of an unrooted phylogenetic tree (performed as above), the
reconstruction of ancestral sequences, the classiﬁcation of the
changes along the tree into the substitutional categories (transi-
tions/trasversions and synonymous/ nonsynonymous), and the
testing for the signature of purifying selection through compar-
isons between categories (Sabath et al., 2011).
Second, rates of synonymous (dS) and nonsynonymous (dN)
substitutions on the P, preS-S, preC-C and X genes were estimated
applying the SLAC method (Kosakovsky Pond and Frost, 2005)
implemented in HYPHY v2.0 (Kosakovsky Pond et al., 2005).
Alignments and phylogenetic trees were used as input for the
analysis and they were constructed as previously. To enable
comparisons across genes and datasets, dN and dS values were
scaled by the total length of the codon tree and thus, the scaled
values represent the expected number of nucleotide substitutions
per codon-site (Kosakovsky Pond and Frost, 2005). Scaled dN and
dS values were compared with Mann-Whitney or Kruskall-Wallis
tests (p<0.05) by using GraphPad v4.02 (GraphPad Software, San
Diego California USA).
Amino acid and codon usages
Amino acid usage was evaluated by three approaches. First,
amino acid composition differences between the overlapping and
nonoverlapping genetic regions were estimated calculating amino
acid frequencies and values were compared grouping amino acids
according to the level of degeneracy of their codifying codons
(high: 6, medium: 3 and 4, or low: 1 and 2 synonymous codons).
Second, the amino acid substitution pattern was studied for each
genetic region. This analysis was carried out by using DAMBE
v5.0.7 (Xia and Xie, 2001). Standardized physicochemical classes of
the 20 common amino acids were deﬁned according to the
international ImMunoGeneTics information system® (IMGT®)
database (Pommie et al., 2004). This classiﬁcation was used to
analyse the type of nonsynonymous changes occurring in the
different regions of the genome. Observed and expected amino
acid substitutions within a single class were compared for each
genetic region, whereas observed substitutions for overlapping
and nonoverlapping regions were also compared. For these com-
parisons, the Proportion tests (p<0.05) implemented in GraphPad
v4.02 was used. Finally, the amino acid diversity for each genetic
region was estimated by using MEGA v5.05 (Tamura et al., 2011).
The amino acid substitution matrix used for each region was
selected among those available in MEGA with the ProtTest v2.4
software (Abascal et al., 2005), according to the Akaike Informa-
tion Criterion.
Codon usage was evaluated calculating the Relative Synon-
ymous Codon Usage (RSCU) index for each synonymous codon in
all genetic regions by using DAMBE v5.0.7. The RSCU value of a
codon is its observed frequency divided by its expected frequency
in the absence of usage bias (Sharp and Li, 1986). The correlation
among RSCU values from overlapping and nonoverlapping regions
was analysed using the Spearman correlation test (p<0.05) with
the GraphPad software. A signiﬁcant correlation would mean a
similar codon usage among the regions compared, whereas a
nonsigniﬁcant correlation would imply a lack of evidence of a
similar codon usage. Stop codons and codons that code only for
one amino acid (ATG: methionine and TGG: tryptophan) were not
considered in the analysis.
On the other hand, to comparatively evaluate the HBV and
human codon usages, human tissue-speciﬁc gene expression data
were obtained from previous studies (Hsiao et al., 2001; Plotkinet al., 2004) and the correlation among RSCU values was analysed
using the most expressed liver (n¼33; ∼37800 codons) and brain
(n¼40; ∼39100 codons) human genes.
Differential adaptive evolution according to the HBeAg(þ)/(−) status
To test whether differential adaptive evolution according to the
HBeAg status occurs in the HBV genome, a method for detecting
differential selective pressure on individual sites between popula-
tions was applied (Pond et al., 2006), by using the HYPHY v2.0
software. Thus, sequences classiﬁed as HBeAg(þ) (Dataset A) were
compared with sequences classiﬁed as HBeAg(−) (n¼119) (Dataset
B). Alignments and phylogenetic trees were built as previously.
The association of the differentially selected sites with epitopes
B and T was evaluated with the Immune Epitope Database (IEDB)
(Vita et al., 2010).Acknowledgments
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